ES530691A0 - Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal. - Google Patents

Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal.

Info

Publication number
ES530691A0
ES530691A0 ES530691A ES530691A ES530691A0 ES 530691 A0 ES530691 A0 ES 530691A0 ES 530691 A ES530691 A ES 530691A ES 530691 A ES530691 A ES 530691A ES 530691 A0 ES530691 A0 ES 530691A0
Authority
ES
Spain
Prior art keywords
derivative
crosslinked fibrin
fibrin derivative
extract
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530691A
Other languages
English (en)
Spanish (es)
Other versions
ES8507694A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fielder Gillespie Davis Ltd
Original Assignee
Fielder Gillespie Davis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3770042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES530691(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fielder Gillespie Davis Ltd filed Critical Fielder Gillespie Davis Ltd
Publication of ES8507694A1 publication Critical patent/ES8507694A1/es
Publication of ES530691A0 publication Critical patent/ES530691A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES530691A 1983-03-17 1984-03-16 Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal. Granted ES530691A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPF849483 1983-03-17

Publications (2)

Publication Number Publication Date
ES8507694A1 ES8507694A1 (es) 1985-09-01
ES530691A0 true ES530691A0 (es) 1985-09-01

Family

ID=3770042

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530691A Granted ES530691A0 (es) 1983-03-17 1984-03-16 Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal.

Country Status (18)

Country Link
US (1) US4758524A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0122478B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59183696A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR840008288A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE99738T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU572125B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1247022A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3486262T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK158284A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES530691A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR81951B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL71264A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN158324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO167338C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ207459A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH22957A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT78267B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA841878B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
JPS60166698A (ja) * 1984-02-09 1985-08-29 Dai Ichi Pure Chem Co Ltd モノクロ−ナル抗体
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
FR2569276B1 (fr) * 1984-08-14 1988-02-05 Stago Diagnostica Procede de dosage de produits de degradation du fibrinogene
US5116613A (en) * 1985-01-08 1992-05-26 The General Hospital Corporation Antibody-thrombolytic agent product and method of use
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JPH0746104B2 (ja) * 1986-09-22 1995-05-17 株式会社ヤトロン Ｆｄｐの測定法
FI89634C (fi) * 1987-07-10 1993-10-25 Yamanouchi Pharma Co Ltd Foerfarande, anordning och kitt foer maetning av vaevnadsplasminogenaktivator-aktivitet
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US5453359A (en) 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5206140A (en) * 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
IE67430B1 (en) * 1988-06-24 1996-04-03 Res Corp Technologies Inc Assay for soluble crosslinked fibrin polymers
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
CA2023354C (en) * 1989-08-17 2002-08-13 Karen Ann Thomas Method for direct chemical binding of d-dimer from a biological sample for diagnosing and monitoring thrombolytic and hypercoagulable states
WO1991002547A1 (en) * 1989-08-24 1991-03-07 Australian Nuclear Science & Technology Organisation Radio-labelled antibodies for imaging
FR2663748B1 (fr) * 1990-06-22 1992-10-09 Oris Ind Cie Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
EP0955066A3 (en) * 1992-07-31 2002-08-28 Australian Nuclear Science And Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5487892A (en) * 1994-02-24 1996-01-30 American Biogenetic Sciences, Inc. Method for treating thrombotic disease using a fibrin specific monoclonal antibody
EP0937146A2 (en) * 1996-09-20 1999-08-25 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
AU2002232518A1 (en) * 2000-11-13 2002-05-21 Sigma-Aldrich Co. Improved assay and reagents or immunological determination of analyte concentration
WO2002046769A2 (en) * 2000-12-05 2002-06-13 The Penn State Research Foundation A monoclonal antibody-based diagnostic assay for gamma fibrinogen
AU2002318960B2 (en) 2001-06-26 2008-05-15 Agen Biomedical Limited Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin
US7485438B2 (en) * 2002-03-01 2009-02-03 Szu-Yi Chou Method of producing polyvalent antigens
US20030224476A1 (en) * 2002-03-01 2003-12-04 Szu-Yi Chou Method of producing transglutaminase reactive compound
US20030219853A1 (en) * 2002-03-01 2003-11-27 Szu-Yi Chou Method of cross-linking a compound
US20040001848A1 (en) * 2002-03-01 2004-01-01 Szu-Yi Chou Method of producing disease-specific antigens
DE102004052082A1 (de) 2004-10-26 2006-04-27 Dade Behring Marburg Gmbh Durchstoßbare, flexible Vorrichtung zur Abdeckung von Flüssigkeitsbehältnissen
US11506674B2 (en) 2005-07-29 2022-11-22 Princeton Biomeditech Corporation Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
US8940489B2 (en) 2005-07-29 2015-01-27 Hyun-Ju Doh Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
WO2011125875A1 (ja) * 2010-04-01 2011-10-13 三菱化学メディエンス株式会社 新規モノクローナル抗体ならびにｄダイマーの免疫学的測定法
EP2600151B1 (en) 2010-07-30 2016-12-21 Sysmex Corporation Reagent and reagent kit for measurement of fdp, and measurement method
TWI658268B (zh) * 2017-11-29 2019-05-01 國立清華大學 血液檢測方法
JPWO2021200131A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 2020-03-30 2021-10-07

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
EP0113075A3 (en) * 1982-12-06 1985-05-02 Fielder Gillespie Davis Limited Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith
AU2373384A (en) * 1982-12-06 1984-06-14 Fielder Gillespie Davis Ltd. Field immunoassay reaction system
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II

Also Published As

Publication number Publication date
ZA841878B (en) 1984-10-31
GR81951B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-12-12
ES8507694A1 (es) 1985-09-01
EP0122478B1 (en) 1994-01-05
DE3486262D1 (de) 1994-02-17
DK158284A (da) 1984-09-18
CA1247022A (en) 1988-12-20
DE3486262T3 (de) 2000-10-26
IL71264A (en) 1987-10-20
PT78267A (en) 1984-04-01
JPS59183696A (ja) 1984-10-18
EP0122478B2 (en) 2000-04-12
ATE99738T1 (de) 1994-01-15
KR840008288A (ko) 1984-12-14
IN158324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-10-18
PT78267B (en) 1986-04-21
JPH0583240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-11-25
NO167338C (no) 1993-12-15
AU2538784A (en) 1984-09-20
DE3486262T2 (de) 1994-06-16
PH22957A (en) 1989-02-03
NO167338B (no) 1991-07-15
DK158284D0 (da) 1984-03-16
US4758524A (en) 1988-07-19
NO841023L (no) 1984-09-18
AU572125B2 (en) 1988-05-05
EP0122478A2 (en) 1984-10-24
NZ207459A (en) 1987-11-27
IL71264A0 (en) 1984-06-29
EP0122478A3 (en) 1987-04-01

Similar Documents

Publication Publication Date Title
ES530691A0 (es) Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal.
Maizels et al. Phosphorylcholine‐bearing antigens in filarial nematode parasites: analysis of somatic extracts, in‐vitro secretions and infection sera from Brugia malayi and B. pahangi
Avrameas Coupling of enzymes to proteins with glutaraldehyde: use of the conjugates for the detection of antigens and antibodies
CA1270194A (en) Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
NO166465C (no) Fremgangsmaate for bestemmelse av sekvensen av monomerer.
US4379839A (en) Method for detecting cancer
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
EP0585960A3 (en) Diagnostic method for autoimmune diseases
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
DE69123723D1 (de) Diagnostisches verfahren und reagenz für hiv
DE59106634D1 (de) Pankreas-elastase-1-spezifischer antikörper, ein verfahren zu seiner gewinnung und ein testkit der solche antikörper enthält.
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
Sandeman et al. Precipitating antibodies against excretory/secretory antigens of Fasciola hepatica in sheep serum
CA1287801C (en) Method for determining human collagen peptides by way of enzyme immunoassay
NO165128C (no) Fremgangsmaate for eliminering av falske positive resultater fra systemiske lupuserythematodes-pasienter ved bestemmelse av et atl-virusantistoff i en testproeve.
JPS55152458A (en) Method of eliminating immunoreaction interference in immunological measurement method
Van Rooijen et al. Double immunocytochemical staining in the study of antibody-producing cells in vivo. Simultaneous detection of anti-hapten and anti-carrier antibody-producing cells in lymphoid tissue
EP0220702A3 (en) Method for the preparation of monoclonal antibody derived from immunoreactive trypsin
Guerret et al. Immunohistochemical micromethods for the measurement of specific collagen types in human liver biopsies
Chi et al. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum
US4442088A (en) Tumor enzyme detection
US4876192A (en) Detection of antibodies against a chorionic gonadotropin-like substance
JPS5646465A (en) Measuring method for man pancreas secretory inhibiter in humor
GB1514639A (en) Test method to determine pulmonary embolism
JPS6488368A (en) Method for measuring complex of urokinase and urokinase inhibitor

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050510